Feed:All articles/Pretty: Difference between revisions

Feed:All articles/Pretty (view source)

7 bytes removed , 9 May 2018

no edit summary

Bots, editor, reviewer, Administrators

13,941

edits

@@ Line 2,949: / Line 2,949: @@
           },
           {
-             "timestamp" : "2018-02-01T19:01:17Z",
+             "timestamp" : "2018-05-09T14:45:19Z",
              "briefDesignDescription" : "Edoxaban vs. LMWH in cancer VTE",
              "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1711948",
@@ Line 2,955: / Line 2,955: @@
              "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1711948",
              "trainingLevel" : "Resident",
-             "citation" : "Raskob GE, <i>et al</i>. \"Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism\". <i>The New England Journal of Medicine</i>. 2017. e-pub 2017-12-12:1-10.",
+             "citation" : "Raskob GE, <i>et al</i>. \"Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism\". <i>The New England Journal of Medicine</i>. 2018. 378(7):615-624.",
              "subspecialties" : "Hematology;Pulmonology",
              "expansion" : "",
              "statusUsableDate" : "2018-02-01",
              "briefResultsDescription" : "Edoxaban noninferior to dalteparin in cancer VTE",
-             "published" : "2012-12-12",
+             "published" : "2018-02-15",
              "pageName" : "Hokusai VTE Cancer Trial",
              "diseases" : "Venous Thromboembolism;Pulmonary Embolism;Deep Vein Thrombosis",